Abstract
BackgroundPatients with ankylosing spondylitis (AS) have higher risk of atherosclerotic cardiovascular disease (CVD) than the general population, but few have studied soluble biomarkers of CVD in AS. Asymmetric dimethylarginine (ADMA)...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
